In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
{{output}}
Since its inception, SARS-CoV-2 has crossed all borders and continues rampaging around the globe, causing profound economic damage and heavy burden on the scientific community and the healthcare fraternity and facilities. With the emergence of new variants, th... ...